Navigation Links
Transave Issued Key Composition of Matter Patent for ARIKACE™
Date:5/24/2010

at enable penetration of the biofilm.  ARIKACE is administered once daily using a customized Investigational eFlow® Nebulizer System (PARI Pharma GmbH), a novel, highly efficient and portable aerosol delivery system enabling more effective distribution in the lungs.  

Positive results were announced in October 2009 from pooled results of two Phase 2 clinical trials in the treatment of CF patients with Pseudomonas lung infections.  The company also previously announced positive Phase 2 results in September 2009 in the treatment of non-CF bronchiectasis patients who have Pseudomonas lung infections.  

ARIKACE has been granted orphan drug status in the United States by the FDA, and has received an orphan drug designation in Europe by the European Medicines Agency for the treatment of Pseudomonas infections in patients with CF.  ARIKACE has also been granted orphan drug status by the FDA for the treatment of bronchiectasis in patients with Pseudomonas or other susceptible pathogens.  

About the Investigational eFlow® Nebulizer System and PARI Pharma

ARIKACE is delivered by an Investigational eFlow® Nebulizer System developed by PARI Pharma and optimized specifically for ARIKACE. The Investigational eFlow Nebulizer System uses eFlow Technology to enable highly efficient aerosolization of medication including liposomal formulations via a vibrating, perforated membrane that includes thousands of laser drilled holes. Compared to other nebulization technologies, eFlow Technology produces aerosols with a very high density of active drug, a precisely defined droplet size, and a high proportion of respirable droplets deli
'/>"/>

SOURCE Transave, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Transave Enters Into Cooperative Research Agreement With NIH To Study ARIKACE(TM) In Nontuberculous Mycobacteria
2. Transave, Inc. Secures $12.5 Million in New Financing
3. Transave, Inc. Raises $35 Million Through Series D Convertible Preferred Stock Financing
4. Details Issued Today on $1 Billion in Biotech Tax Credits and Grants
5. Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate
6. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
7. Prometheus Strengthens Intellectual Property Portfolio with Newly Issued Patents for Thiopurine Metabolite Testing
8. Arobella Medical CEO is Issued U.S. Patent for Ultrasound Wound Therapy Technology
9. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q4/08 Review Issued by Scimitar Equity, LLC
10. VioQuest Pharmaceuticals, Inc Q2/08 Review Issued by Scimitar Equity, LLC
11. VioQuest Pharmaceuticals, Inc Valuation Upgrade Review Issued By Scimitar Equity, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the ... Q3 orders to $5.8 million and provides a good start to ... North America and one in the ... projects at record levels," said Peter Bruijns , President & ... end of Q3 than they have been for any complete year ...
(Date:10/20/2014)... Earle Martin , Chief Executive ... Ellen Teplitzky, an experienced attorney specializing in business ... has joined the firm as Director of Legal ... NDA Partners provides legal services, including research, ... top law firms and their clients in cases ...
(Date:10/19/2014)... The Asia-Pacific Bromine Market report defines and ... and forecast of revenue. , Browse through the ... to get an idea of the in-depth analysis ... segmentation in the Asia-Pacific bromine market, and is ... http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html , Bromine is a volatile ...
(Date:10/19/2014)... The report "Unmanned Ground Vehicle Market by ... Type & by Geography - Forecasts & Analysis ... vehicle market into various sub segments with an ... report also identifies the factors driving this market, ... the adoption trends. , The unmanned ground vehicle ...
Breaking Biology Technology:NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 2Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 3Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 4Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 5
... Mass., May 11 Boston Scientific Corporation (NYSE: ... Company,s major events and news announcements at the 30th ... run from May 13 to 16 in Boston. ... from the MADIT II clinical trial and the ALTITUDE ...
... VANCOUVER, May 11 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ... final survival data from a randomized Phase 2 ... docetaxel alone as first-line chemotherapy in patients with ... an oral presentation at the American Society of ...
... 11 Dalton Pharma Services and ProCitius Research jointly ... contract chemistry services of exceptional ... their discovery and development output in an era of ... "offshore" contract research organizations (CROs) ...
Cached Biology Technology:Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions 2Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions 3Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions 4Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions 5OncoGenex Pharmaceuticals' Clinical Programs to be Featured in Oral Presentations at the American Society of Clinical Oncology Annual Meeting 2OncoGenex Pharmaceuticals' Clinical Programs to be Featured in Oral Presentations at the American Society of Clinical Oncology Annual Meeting 3Dalton Pharma Services and ProCitius Announce a Strategic Alliance to Provide Contract Chemistry Services 2Dalton Pharma Services and ProCitius Announce a Strategic Alliance to Provide Contract Chemistry Services 3
(Date:10/17/2014)... release is available in German . ... of sperms every day in order to reproduce? And why ... the topic of the latest issue of the research journal ... The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld has ... is not unusual for a female to copulate with several ...
(Date:10/16/2014)... Institute of Marine Science have received a 3-year, ... identify the streams and wetlands most vulnerable to ... local governments and citizens conserve these important ecosystems. ... of tidal-marsh observations first gathered by VIMS scientists ... can today,s researchers accurately map the slow but ...
(Date:10/16/2014)... infections and worldwide claims the lives of 160,000 ... University have succeeded in developing a promising vaccination ... , Xavier Saelens (VIB/UGent): "We discovered a new ... development of a novel approach to vaccination against ... small children and elderly people." , RSV: ...
Breaking Biology News(10 mins):Sperm wars 2EPA grant will help localities conserve headwater wetlands 2EPA grant will help localities conserve headwater wetlands 3New perspectives for development of an RSV vaccine 2
... have developed a computer-aided method that uses electronic ... advances toward personalized health care, disease management and ... Chawla and his doctoral student, Darcy A. Davis, ... Engine (CARE) for personalized disease risk predictions and ...
... A forest full of rabbits and foxes, a bubbling ... a cell are, to a computer, similar systems: Many ... of rules and individual interactions that can,t be precisely ... pathways, or rabbits multiplying or getting eaten. Predicting ...
... WA, and Ahmedabad, India, July 25, 2013: In ... group and an innovation-led global healthcare provider, and ... organization, announced today they are collaborating on the ... (VL) vaccine candidate, designed to prevent the deadly ...
Cached Biology News:Notre Dame researchers develop system that uses a big data approach to personalized healthcare 2Computer can infer rules of the forest 2IDRI and Zydus sign agreement for development of IDRI's vaccine candidate for visceral leishmaniasis 2
... The GSTTag Monoclonal Antibody is a ... affinity to the 26 kDa glutathione-S-transferase ... This purified antibody is suitable for ... sequence expressed in E. coli , ...
... LNA microarray slides for microRNA expression ... incorporate Exiqons unique Locked Nucleic Acid (LNA) ... mismatch discrimination for short microRNA (miRNA) targets. ... 1 g total RNA (no need for ...
... there have been many modifications to the original ... salt solutions still play an important role in ... the pH and osmotic balance in the medium ... essential inorganic ions, is as valuable today as ...
Imject Freund's Complete Adjuvant (FCA)...
Biology Products: